CD86 and breast cancer: The BC-BM pair ratios of CD86+ M1 to CD163+ M2 macrophages and CD86+ M1 to CD206+ M2 macrophages in the HER2-positive subtype tended to be higher in primary BC than in BCBM (p = 0.1 and p = 0.085, respectively) (Figure S4b).